Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets
M Nimgampalle, V Devanathan… - Journal of Biomolecular …, 2021 - Taylor & Francis
Recently Chloroquine and its derivative Hydroxychloroquine have garnered enormous
interest amongst the clinicians and health authorities' world over as a potential treatment to …
interest amongst the clinicians and health authorities' world over as a potential treatment to …
In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2
The global health emergency of novel COVID-19 is due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …
Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2
Novel coronavirus SARS-CoV-2 has infected 18 million people with 700,000+ mortalities
worldwide and this deadly numeric figure is rapidly rising. With very few success stories, the …
worldwide and this deadly numeric figure is rapidly rising. With very few success stories, the …
Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein – an in silico insight into the …
M Amin, G Abbas - Journal of Biomolecular Structure and …, 2021 - Taylor & Francis
Recent outbreak of novel Coronavirus disease () pandemic around the world is associated
with severe acute respiratory syndrome. The death toll associated with the pandemic is …
with severe acute respiratory syndrome. The death toll associated with the pandemic is …
Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study
I Celı̇k, A Onay-Besı̇kcı̇… - Journal of Biomolecular …, 2021 - Taylor & Francis
We aimed to analyze the interactions of both hydroxychloroquine and chloroquine with
SARS-CoV-2 and identify their possible role for the prevention/treatment of COVID-19 by …
SARS-CoV-2 and identify their possible role for the prevention/treatment of COVID-19 by …
In silico insight into the interaction of 4-aminoquinolines with selected SARS-CoV-2 structural and nonstructural proteins
H Tijjani, A Olatunde, AP Adegunloye… - Coronavirus Drug …, 2022 - Elsevier
The development of efficacious therapeutic agents with relatively low or no level of toxicity
was necessitated due to the reemergence of coronavirus. The present study investigated the …
was necessitated due to the reemergence of coronavirus. The present study investigated the …
[PDF][PDF] The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2
RR Narkhede, RS Cheke, JP Ambhore… - Eurasian Journal of …, 2020 - academia.edu
Objectives: The novel human coronavirus designated severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
Discovery of potential SARS-CoV 3CL protease inhibitors from approved antiviral drugs using: virtual screening, molecular docking, pharmacophore mapping …
The spread of corona-virus disease 2019 (COVID-19) has been faster than any other corona-
viruses that have succeeded in crossing the animal-human barrier. This disease, caused by …
viruses that have succeeded in crossing the animal-human barrier. This disease, caused by …
In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection
HLB Braz, JA de Moraes Silveira, AD Marinho… - International journal of …, 2020 - Elsevier
ABSTRACT Coronavirus disease 2019 (COVID-19) is a highly transmissible viral infection
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical trials …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical trials …
Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19 …
Now a days, more than 200 countries faces the health crisis due to epidemiological disease
COVID-19 caused by SARS-CoV-2 virus. It will cause a very high impact on world's …
COVID-19 caused by SARS-CoV-2 virus. It will cause a very high impact on world's …
相关搜索
- sars cov action of hydroxychloroquine
- sars cov therapeutic targets
- sars cov drug candidates
- sars cov covid 19
- drug candidates therapeutic targets
- sars cov silico insight
- sars cov molecular dynamics
- hydroxychloroquine interaction antiviral drugs
- virtual screening cov 3cl
- sars cov main protease
- sars cov mechanism of action